In summary, Nrf2 is involved in metastasis, treatment resistance, and the progression of many cancers, including pancreatic cancer, squamous cell carcinoma, lung cancer, breast cancer, and leukemia. This evidence concerns the gene NFE2L2 and lung carcinoma.